Comments
Loading...

Entrada Therapeutics

TRDANASDAQ
Logo brought to you by Benzinga Data
$13.65
-0.51-3.60%
At Close: -
$13.65
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
75%
Overview Rating
Good
Technicals Analysis
66
0100
Financials Analysis
80
0100
80%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
0
0
0
0
Jun
1
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Entrada Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of p...
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
TRDA
KALV

FAQ

Q

How do I buy Entrada Therapeutics (TRDA) stock?

A

You can purchase shares of Entrada Therapeutics (NASDAQ:TRDA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Entrada Therapeutics (TRDA) competitors?

Q

What is the forecast, or price target, for Entrada Therapeutics (TRDA) stock?

A

Entrada Therapeutics has a consensus price target of $20.75.

Q

What is the current price for Entrada Therapeutics (TRDA)?

A

The stock price for Entrada Therapeutics (NASDAQ: TRDA) is $13.65 last updated September 18, 2024 at 4:00 PM EDT.

Q

Does Entrada Therapeutics (TRDA) pay a dividend?

A

There are no upcoming dividends for Entrada Therapeutics.

Q

When is Entrada Therapeutics (NASDAQ:TRDA) reporting earnings?

A

Entrada Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.

Q

Is Entrada Therapeutics (TRDA) going to split?

A

There is no upcoming split for Entrada Therapeutics.

Q

What sector and industry does Entrada Therapeutics (TRDA) operate in?

A

Entrada Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch